Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
CMS, Incyte settle lawsuit on classification of Opzelura
Incyte has dropped a lawsuit against the CMS, as the agency has agreed not to classify Opzelura together with Jakafi.
Kevin Dunleavy
Jun 23, 2026 1:32pm
Regulatory tracker: Braftovi nabs 1st-line expansion in Europe
Jun 23, 2026 10:45am
Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
Brought to you by
DKSH
Novartis’ ‘Relax Your Tight End’ wins Cannes Pharma Grand Prix
Jun 23, 2026 9:06am
The legacy approach to real-world data is costing you
Brought to you by
HealthVerity
Obesity meds, China drive $2T in projected 2032 drug sales: report
Jun 23, 2026 9:00am
